(Q30662784)

26 June 2017

title

Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting. (English)

1 reference

26 June 2017

1 reference

Dagar S

1

1 reference

26 June 2017

Sekosan M

series ordinal

2

1 reference

26 June 2017

Rubinstein I

series ordinal

3

1 reference

26 June 2017

Onyüksel H

series ordinal

4

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Breast Cancer Research and Treatment

26 June 2017

published in

1 reference

26 June 2017

volume

65

1 reference

26 June 2017

issue

1

1 reference

26 June 2017

page(s)

49-54

1 reference

26 June 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

Vasoactive intestinal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

Stimulation of tumor cell growth by vasoactive intestinal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

Molecular characteristics and evidence for internalization of vasoactive-intestinal-peptide (VIP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2 J.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

Polypeptide with Broad Biological Activity: Isolation from Small Intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

VIP and breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

In vitro identification of VIP receptors in human tumors: potential clinical implications.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

Pathogenic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

Decrease in immunoreactive neutral endopeptidase in uvula epithelium of patients with obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

Targeting of Drugs to Solid Tumors Using Anti-Her2 Immunoliposomes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

(Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006406617497

7 January 2021

Identifiers

DOI

10.1023/A:1006406617497

1 reference

Dimensions Publication ID

26 June 2017

1000629956

0 references

1 reference